On October 21, the U.S. Food and Drug Administration (FDA) approved a new therapy that could improve the lives of thousands of people living with cystic fibrosis (CF). The first triple combination therapy has been made available to treat patients with the most ...
from Google Alert - health https://ift.tt/32SHqyd
via IFTTT
0 comments:
Post a Comment